Idexx Laboratories Share Price Today
(NASDAQ: IDXX)

Name: Idexx Laboratories Share Price Today (NASDAQ: IDXX) - Idexx Laboratories Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Idexx Laboratories share price is $431.92 & ₹36,578.23 as on 30 Apr 2025, 23.39 hrs IST

$431.92

▲

-5.05

(-1.16%)

Live

View live Idexx Laboratories share price in Dollar and Rupees. Guide to invest in Idexx Laboratories stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Idexx Laboratories, along with analyst recommendations, forecasts, and comprehensive financials.

Idexx Laboratories (IDXX) Key Statistics

in dollars & INR

Previous Close	$436.97
Open	$433.69
Today's High	$435.94
Today's Low	$428.09
Market Capitalization	$35.5B
Today's Volume	$718.0K
Revenue TTM	$3.9B
EBITDA	$1.3B
Earnings Per Share (EPS)	$10.67
PE Ratio	40.67
Profit Margin	22.78%
Quarterly Earnings Growth YOY	0.13%
Return On Equity TTM	57.66%

How to invest in Idexx Laboratories Stock (IDXX) from India?

It is very easy for Indian residents to invest directly in Idexx Laboratories from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Idexx Laboratories stock in both Indian Rupees (INR) and US Dollars (USD). Search for Idexx Laboratories or IDXX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Idexx Laboratories or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Idexx Laboratories shares which would translate to 0.002 fractional shares of Idexx Laboratories as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Idexx Laboratories, in just a few clicks!

Returns in Idexx Laboratories (IDXX) for Indian investors in Rupees

The Idexx Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Idexx Laboratories investment value today

Current value as on today

₹89,139

Returns

₹10,861

(-10.86%)

Returns from Idexx Laboratories Stock

₹12,347 (-12.35%)

Dollar Returns

₹1,486 (+1.49%)

Indian investors sentiment towards Idexx Laboratories (IDXX)

Period: Mar 30, 2025 to Apr 29, 2025. Change in 30 Days versus previous period

Search interest for Idexx Laboratories Stock from India on INDmoney has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Idexx Laboratories Stock (IDXX Ticker)

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	692	1.01	0.07%
ICICI Prudential NASDAQ 100 Index Fund Direct Growth	1043	8.29	0.24%

Global Institutional Holdings in Idexx Laboratories

Vanguard Group Inc
11.94%
BlackRock Inc
10.42%
State Street Corp
4.47%
Fundsmith LLP
3.27%
Geode Capital Management, LLC
2.82%
BAMCO Inc
2.47%

Analyst Recommendation on Idexx Laboratories

Rating

Trend

Buy

68%Buy

31%Hold

0%Sell

Based on 19 Wall street analysts offering stock ratings for Idexx Laboratories(by analysts ranked 0 to 5 stars)

Analyst Forecast on Idexx Laboratories Stock (IDXX)

What analysts predicted

Upside of 12.55%

Target:

$486.13

Current:

$431.92

Insights on Idexx Laboratories Stock (Ticker Symbol: IDXX)

Price Movement
In the last 3 months, IDXX stock has moved up by 3.1%
Decreasing Revenue
Idexx Laboratories, Inc. has experienced a decline in revenue over the last three quarters. The revenue decreased from $1.00 billion to $954.28 million, reflecting an average decrease of 2.5% each quarter.
Decreasing Net Profit
Idexx Laboratories, Inc. has experienced a decline in net profit over the last two quarters. Specifically, their net profit decreased from $232.84 million to $216.14 million, resulting in an average decrease of 7.2% per quarter.

Idexx Laboratories Technicals Summary

Sell

Neutral

Buy

Idexx Laboratories is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Idexx Laboratories (IDXX) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Idexx Laboratories, Inc.	4.08%	-3.11%	-11.3%	1.07%	61.43%
Agilent Technologies Inc.	-8.16%	-18.29%	-21.6%	-10.15%	44.77%
Thermo Fisher Scientific, Inc.	-14.07%	-22.35%	-24.82%	-21.62%	29.64%
Danaher Corp.	-2.94%	-17.89%	-19.32%	-20.58%	23.76%
Iqvia Holdings Inc.	-12.95%	-28.96%	-33.78%	-29.3%	12.42%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Idexx Laboratories, Inc.	40.67	40.67	3.72	11.99	0.58	0.23	NA	19.55
Agilent Technologies Inc.	24.51	24.51	1.74	5.55	0.21	0.08	0.01	21.13
Thermo Fisher Scientific, Inc.	24.71	24.71	1.63	22.52	0.14	0.05	0.0	130.57
Danaher Corp.	37.89	37.89	1.94	7.7	0.07	0.04	0.01	71.06
Iqvia Holdings Inc.	20.07	20.07	0.8	11.83	0.23	0.05	NA	34.45

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Idexx Laboratories, Inc.	Buy	$35.5B	61.43%	40.67	22.78%
Agilent Technologies Inc.	Buy	$30.7B	44.77%	24.51	19.27%
Thermo Fisher Scientific, Inc.	Buy	$160.0B	29.64%	24.71	15.19%
Danaher Corp.	Buy	$140.2B	23.76%	37.89	15.81%
Iqvia Holdings Inc.	Buy	$26.5B	12.42%	20.07	8.91%

About Idexx Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Organization	Idexx Laboratories
Employees	11000
CEO	Mr. Jonathan J. Mazelsky
Industry	Health Technology

Management People of Idexx Laboratories

Name	Title
Mr. Jonathan J. Mazelsky	President, CEO & Director
Mr. Brian P. McKeon	Executive VP & Special Advisor
Mr. Michael J. Lane	Executive VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology
Dr. Nimrata Khatra Hunt P.E., Ph.D.	Executive Vice President of Global Strategy & Commercial
Dr. Martin Smith Ph.D.	Executive Vice President of Global Operations and R&D
Mr. Andrew Emerson	Executive VP, CFO & Treasurer
Mr. Bob Asmann	Senior Vice President of Global Operations
Ms. Sharon E. Underberg J.D.	Executive VP, General Counsel, & Corporate Secretary
Ms. Julie Godon	Senior VP & Global Marketing Officer
Mr. Michael P. Johnson	Executive VP & Chief Human Resources Officer

Important FAQs about investing in IDXX Stock from India :

What is Idexx Laboratories share price today?

Idexx Laboratories share price today stands at $431.92, Open: $433.69 ; Previous Close: $436.97 ; High: {{1_rba_end}} ; Low: {{1_rba_st}} ; 52 Week High: {{rba_end}} ; 52 Week Low: {{rba_st}}.

The stock opens at $433.69, after a previous close of $436.97. The stock reached a daily high of {{1_rba_end}} and a low of {{1_rba_st}}, with a 52-week high of {{rba_end}} and a 52-week low of {{rba_st}}.

Can Indians buy Idexx Laboratories shares?

Yes, Indians can invest in the Idexx Laboratories (IDXX) from India.

With INDmoney, you can buy Idexx Laboratories at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Idexx Laboratories at zero transaction cost.

How can I buy Idexx Laboratories shares from India?

It is very easy to buy Idexx Laboratories from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Idexx Laboratories (IDXX) be purchased?

Yes, you can buy fractional shares of Idexx Laboratories with INDmoney app.

What are the documents required to start investing in Idexx Laboratories stocks?

To start investing in Idexx Laboratories, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.